/Investor DB

Amplitude Venture Capital — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Congruence Therapeuticscongruencetx.cominSeries A · Feb 2022 · $50M

Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico.

AI & Machine LearningBiotechDeep Tech

Clarissa Desjardins(Founder)in

Co-investorsOrbiMedAlexandriaDIMENSIONAngelini VenturesBDC Thrive Lab for WomenBDC Thrive Venture Fund for Women+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Abdera Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.